Mental Imagery Application Protocol for Parkinson's (NCT07193355)

Improve walking confidence through imagery

Trial ID
NCT07193355
Official Title
Effects of Motor Imagery Training on Kinesiophobia, Gait, and Balance in Parkinson's Disease Patients
Goal
Improve walking confidence through imagery
Phase
NA
Status
RECRUITING
Sponsor
Kahramanmaras Sutcu Imam University
Study Type
INTERVENTIONAL
Enrollment
50 participants
Conditions
PARKINSON DISEASE (Disorder), Mental Imagery, Gait Balance
Interventions
Mental Imagery Application Protocol

Summary For Families

The goal is to find out whether a program of motor imagery can lower fear of movement and improve walking and balance in people with Parkinson's. Motor imagery here means a structured program of guided mental practice, where participants imagine performing movements or activating muscles without moving; this kind of mental practice has been used in rehab and limited studies have shown positive trends for balance and fewer falls when added to therapy. The study uses a specific mental imagery protocol and will test its effects on fear of movement, gait, and balance. It is enrolling people aged 40 to 75 with idiopathic Parkinson's up to stage 4 on the Modified Hoehn and Yahr scale, who meet basic thinking and memory screening scores (Mini Mental State Examination 22 or higher if you have formal education, or 18 or higher if not) and who do not have major psychiatric conditions, other neurological or systemic diseases, or hand/arm problems or severe arthritis that would interfere with testing; people taking antipsychotic or antidepressant medications are excluded.

Locations

  • Kahramanmaraş Sütçü imam University, Kahramanmaraş, Onikişubat, Turkey (Türkiye)

Frequently Asked Questions

What is this trial testing?
This trial is studying Mental Imagery Application Protocol. The goal is to find out whether a program of motor imagery can lower fear of movement and improve walking and balance in people with Parkinson's. Motor imagery here means a structured program of guided mental practice, where participants imagine performing movements or activating muscles without moving; this kind of mental practice has been used in rehab and limited studies have shown positive trends for balance and fewer falls when added to therapy. The study uses a specific mental imagery protocol and will test its effects on fear of movement, gait, and balance. It is enrolling people aged 40 to 75 with idiopathic Parkinson's up to stage 4 on the Modified Hoehn and Yahr scale, who meet basic thinking and memory screening scores (Mini Mental State Examination 22 or higher if you have formal education, or 18 or higher if not) and who do not have major psychiatric conditions, other neurological or systemic diseases, or hand/arm problems or severe arthritis that would interfere with testing; people taking antipsychotic or antidepressant medications are excluded.
Who can participate?
Participants must be between 40 Years and 75 Years.
Where is this trial located?
This trial is recruiting at 1 location.
Does it cost anything to join?
You are never charged a fee to join a legitimate clinical trial, and the study treatment and study-specific tests are provided by the trial sponsor at no charge. In the US, routine care you would receive anyway can still be billed to you or your insurance; coverage rules differ by country, and trials in the UK and Canada usually run through public health systems. Travel, parking, and time are real costs, and some trials reimburse them while others do not. Before enrolling, ask the study coordinator to explain in writing what is and is not covered.
How long does the trial last?
This trial is estimated to last approximately 1 year.
Can I leave the trial if I change my mind?
Yes. You can withdraw from any clinical trial at any time, for any reason, without affecting your standard medical care. Trials are voluntary by law. The team may ask if you are willing to do a brief exit visit so they can collect safety information, but you are not obligated.
Can my spouse or care partner come with me to visits?
In most cases yes, and it is often encouraged. Care partners can help with notes, questions, and getting home safely after a long visit. Some study assessments do need to happen one on one, but care partners are usually welcome for the rest of the appointment.
Will I get a placebo in this trial?
This trial has a group that receives no study treatment (you would continue your usual care) alongside the treatment group. Because assignment is random, you have about a 1 in 2 chance (roughly 50%) of being in the no-treatment group, assuming the groups are filled equally. Ask the coordinator to confirm the exact assignment ratio.

Related Reading

View on ClinicalTrials.gov